Ebola in the semen
1. Ebola can
be present in saliva, stool, semen, breast milk, tears, nasal blood, and a skin
swab.
2. A study
published in the Journal of Infectious Diseases (J Infect Dis. 1999 Feb;179
Suppl 1:S28-35) evaluated if convalescent body fluids contain Ebola virus and
if secondary transmission occurs during convalescence. Twenty-nine Ebola
hemorrhagic fever convalescents and their 152 house hold contacts were monitored
for up to 21 months. Blood specimens were obtained and symptom information was
collected from convalescents and their house hold contacts. other body fluid specimens were also obtained
from convalescents. Joint and muscle
pains were reported significantly more often by convalescents than house hold
contacts. Evidence of Ebola virus was detected by reverse
transcription-polymerase chain reaction in semen specimens up to 91 days after
disease onset; however, these and all other non-blood body fluids tested
negative by virus isolation.
Among 81 initially antibody negative house
hold contacts none became antibody positive.
Blood
specimens of 5 house hold contacts not identified as Ebola hemorrhagic
fever patients were initially antibody
positive. No direct evidence of convalescent-to- house hold contract
transmission of Ebola fever was found, although the semen of convalescents may
be infectious.
The
existence of initially antibody-positive house hold contacts suggests that mild
cases of Ebola virus infection occurred.
3. Who is a
high risk Ebola Patient: Percutaneous (needle stick) or mucous membrane
exposure to blood or body fluids (feces, saliva, sweat, urine, vomit, and
semen) of a person with symptomatic Ebola virus disease and Exposure to the
blood or body fluids (feces, saliva, sweat, urine, vomit, and semen) of a
person with symptomatic Ebola virus disease without appropriate personal
protective equipment (PPE). In both
situations a person has to be symptomatic.
4. There is
no identifiable risk when the contact is with an asymptomatic person who had
contact with a person with Ebola and also contact with a person who is later
diagnosed with Ebola virus disease, before the person developed symptoms.
5. Viral persistence — Virus can persist
for some time in certain bodily fluids, such as semen and breast milk.
a Follow-up studies of 40 survivors in
the 1995 Kikwit, Democratic Republic of Congo outbreak showed that viral RNA
sequences could be detected by RT-PCR in the semen of male patients for up to
three months, and infectious virus was recovered from one individual 82 days
after disease onset. [J Infect Dis. 1999;179 Suppl 1:S28.]
b
In only one known instance, during the 1967
Marburg outbreak, has viral persistence in semen led to virus transmission
through sexual contact. [Curr Top Microbiol Immunol. 1999;235:49, Trans R Soc
Trop Med Hyg. 1969;63(3):295.]
c
A study of patient samples collected during
the outbreak of Ebola Sudan virus disease in Gulu, Uganda in 2000 detected
virus in the breast milk of a patient, even after virus was no longer
detectable in the bloodstream. Two children who were breast-fed by
Ebola-infected mothers died of the disease. [J Infect Dis. 2007 Nov;196 Suppl
2:S142-7.]
d
During the 2014 outbreak in West Africa, virus
was cultured from a patient’s urine 12 days after the last positive culture was
identified in plasma. [N Engl J Med. 2014 Oct]
6. Convalescent period of Ebola and
Marburg virus disease is prolonged, and marked by weakness, fatigue, and
failure to regain weight that was lost during illness. Extensive sloughing of
skin and hair loss are commonly observed, possibly as a result of virus-induced
necrosis of infected sweat glands and other dermal structures
7. There is
no evidence that asymptomatic persons
still in the incubation period are infectious to others. But all symptomatic individuals should be
assumed to have virus in the blood, and other body fluids, and appropriate
safety precautions should be taken. [Arch Virol Suppl. 1996;11:141.]
8. Convalescence
from Ebola Virus Disease is long and often associated with sequelae such as
myelitis, recurrent hepatitis, psychosis,
or uveitis. Data on the post-recovery
viraemic period are limited. As said above shedding of Ebola virus has been
reported in breast milk and semen after
the virus has been cleared from blood. Viable virus has been isolated from semen up to many weeks or months after
recovery, and spermatogenic transmission
of Marburg virus has been documented.
There is a paucity of data on Ebola virus in human egg cells. The risk of Ebola
transmission should be considered in connection with reproductive cell
donations, both for ‘partner’ and ‘other
than partner’ donations.
However, the
evidence that Ebola virus may persist for some time in the human body after
recovery from Ebola Fever is insufficient
to define a specific deferral period for donors who have recovered from Ebola
Fever. The current guidance stipulates
deferral for 12 months following
recovery from a viral hemorrhagic fever and this recommendation also applies to donors who have recovered from
Ebola Fever. In addition, living or deceased donors of substances of human origin
should be negative for Ebola virus by NAT testing
9. A deferral
of donation for two incubation periods will provide a reasonable margin of
safety for asymptomatic donors returning from Ebola affected areas. The longest
incubation period for Ebola Disease has been 25 days. Thus, asymptomatic travelers or residents returning from Ebola Virus affected areas should be
temporarily deferred from donation of substance
of human origin including blood for two months after leaving an area affected
by Ebola virus.
10. Men who have recovered from the illness can
still spread the virus to their partner through their semen for many months after
recovery. For this reason, it is important for men to avoid sexual intercourse after
recovery or to wear condoms if having sexual intercourse during this period after
recovery.
[ Dr K K Aggarwal is Padma Shri, Dr B C Roy National and National Science
Communication Awardee, President Heart Care Foundation of India and Senior
National Vice President, Indian Medical Association]
No comments:
Post a Comment